£4.3m boost for Oxford-Glasgow spinout tackling antimicrobial resistance

Published on November 13, 2023

Glox Therapeutics, a company pioneering the development of precision antibiotics to combat antimicrobial resistance, has raised £4.3M in early-stage funding to develop effective targeted therapeutics against antibiotic-resistant gram-negative bacteria. 
Continue reading on website
Other news

AI tool could help thousands avoid fatal heart attacks

November 13, 2023
An AI tool that can predict 10-year risk of deadly heart attacks, could transform treatment for patients who undergo CT scans to investigate chest pain, according to British Heart Foundation-funded research presented today at the American Heart Association’s Scientific Sessions in Philadelphia.

Countries go à la carte with international allegiances, major survey reveals

November 14, 2023
A new multi-country global survey by the European Council on Foreign Relations (ECFR) in cooperation with Oxford University’s ‘Europe in a Changing World’ project reveals stark disparities in attitudes about future world order.Countries no longer want to ‘pick a side’, but choose alliances on the issuesWestern values are admired, but doubts around the survival of the ‘liberal’ WestSurprising numbe